-
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
-
2024-511855-16-00
5
2019-07-25
Onco-hematology
-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2024-515349-41-00
4
2025-07-29
Metastatic Breast Cancer HR+, HER2-
-
2024-516418-39-00
5
2025-07-09
Multiple Myeloma
-
2024-516780-93-00
5
2025-07-09
Sustained immunosuppression
-
2024-510981-18-00
5
2024-12-12
Multiple Myeloma
Multiple myeloma (MM) is a B cell malignancy and is o
-
2024-515118-42-00
11
2024-09-10
Colorectal cancer
-
2024-515297-27-00
5
2024-08-14
colon carcinoma
-
2023-509761-21-00
5
2024-07-08
Metastatic colorectal cancer
-
2023-503317-29-00
5
2024-04-12
Metastatic renal cell carcinoma (mRCC)
-
2024-513669-38-00
5
2023-05-17
Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
-
2022-501494-39-00
5
2023-03-28
Uncontrolled Hypertension IN patients with moderate to severe chronic
-
2024-513671-40-00
5
2022-06-29
HPV vaccine
-
2024-513191-17-00
4
2022-02-03
autoimmune hemolytic anemia
-
2024-517215-67-00
5
2021-06-11
Newly diagnosed Non-Frail transplant Ineligible Multiple Myeloma elder
-
2023-510097-14-00
5
2022-04-15
Patients with MMR deficient relapse or advanced / metastatic endometri
-
2024-514088-25-00
5
2019-10-07
Multiple Myeloma
-
2024-515908-39-00
9
2018-10-29
Patients with metastatic colorectal cancer
-
2024-510704-37-00
5
2017-03-22
ER+/HER2- metastatic breast cancer
-
2024-518741-21-00
4
2014-12-23
colon cancer
-
2022-502372-22-01
4
2023-10-19
Metastatic Breast Cancer HR+, HER2-
-
2024-513532-23-00
5
2021-12-06
early syphilis